Accurate staging for a patient with neuroblastoma is essential. It has implications for prognosis and guides the treatment required for individuals with the disease. In 2009, the INRG project ...

Among patients with low-stage, MYCN-amplified neuroblastoma, outcomes of patients with hyperdiploid tumors were statistically, significantly better than those with diploid tumors. The data suggest ...

Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated. We evaluated 10 consecutive ...

Neuroblastoma is classified using cancer staging, which is a process that determines how far a cancer has spread. Staging helps in two main ways: Examples of the staging and systems of used include ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding a novel ...

In view of the divergent therapeutic approaches, a major goal is to precisely predict each patient's individual risk at the time of diagnosis. Thus, to choose the most appropriate form of treatment, ...

Using machine learning and a large volume of data on genes and existing drugs, researchers at Lund University in Sweden have ...

High-dose chemotherapy (HDC) was investigated in high-risk neuroblastoma (HR-NBL) to reduce the risk of relapse. We report the results of the 30-year experience of a cohort of patients with HR-NBL ...

Clinical responses and disease control observed in 15 of 40 patients with difficult-to-treat refractory pediatric cancers, including 10 of 19 patients treated with elraglusib plus ...

Neuroblastoma is a heterogeneous solid tumor that originates extracranially from neuroblasts. Previous research has demonstrated that miR-492 polymorphisms can contribute to cancer susceptibility.